Currently out of the existing stock ratings of Chiara Russo, 6 are a BUY (50%), 6 are a HOLD (50%).

Chiara Russo

Work Performance Price Targets & Ratings Chart

Analyst Chiara Russo, carries an average stock price target met ratio of 61.11% that have a potential upside of 55.48% achieved within 291 days. Previously, Chiara Russo worked at CANTOR FITZGERALD, JANNEY.

Chiara Russo’s has documented 23 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BDSI, BioDelivery Sciences International at 16-May-2017.

Wall Street Analyst Chiara Russo

Analyst best performing recommendations are on ASRT (ASSERTIO THERAPEUTICS).
The best stock recommendation documented was for ASRT (ASSERTIO THERAPEUTICS) at 3/19/2015. The price target of $88 was fulfilled within 7 days with a profit of $11.48 (11.54%) receiving and performance score of 16.49.

Average potential price target upside

ASRT Assertio Therapeutics BDSI BioDelivery Sciences International ICPT Intercept Pharmaceuticals TNXP Tonix Pharmaceuticals Holding Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 05-May-2026

$21.8

$-1.7 (-7.23%)

$18

2 months 7 days ago
(05-May-2026)

0/9 (0%)

$-0.36 (-1.62%)

Buy Since 07-Nov-2022

$18

$-5.5 (-23.40%)

$3

3 months 3 days ago
(09-Apr-2026)

1/6 (16.67%)

$-0.02 (-0.11%)

612

Buy Since 09-Nov-2021

$2.75

$-20.75 (-88.30%)

$3.5

2 years 1 months 14 days ago
(28-May-2024)

0/3 (0%)

$-12.25 (-81.67%)

Buy Since 18-May-2022

$4

$-14.02 (-77.80%)

2 years 8 months 9 days ago
(03-Nov-2023)

0/2 (0%)

$-31.1 (-88.60%)

Hold Since 22-Feb-2017

$16

$4.22 (35.82%)

$52

6 years 11 months 3 days ago
(08-Aug-2019)

0/4 (0%)

$4.76 (42.35%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Chiara Russo?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?